Fundraising FoxLodo Therapeutics
New York, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into Lodo Therapeutics
Sign up to see every warm intro you have to Lodo Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lodo Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DP
David PomplianoExecutive
DM
David McElligottExecutive
Board
DS
David SchubertBoard director
JM
LR
Lindsay RayleBoard director
BD
Barbara DaltonBoard director
SG
MJ
M. Johnston ErwinBoard director
MU
Misti UshioBoard directorSteering Board; Managing Partner, Digitalis Ventures at Blackbird Bioventures
TL
Thong LeBoard director
AX
Asish XavierBoard director
JS
James SullivanBoard director
Investors · 5
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us
AbbViereportedCambridge · $300K – $3M
How we know: funding news · Not right? Tell us
AlexandriareportedPasadena
How we know: funding news · Not right? Tell us
ARCH Venture PartnersreportedChicago · $50K – $250M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.9M disclosed across 1 round · 2015
▶$19.9MraisedJan 2017 · 13 investors · BiotechnologyRule 506(b)
▶$19.9MraisedJan 2017 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David SchubertExecutive Officer, Promoter
- Joel MarcusDirector
- Lindsay RayleExecutive Officer, Promoter
- Barbara DaltonDirector
- Steve GillisDirector
- David PomplianoExecutive Officer
- M. Johnston ErwinDirector
- Misti UshioDirector
- Thong LeExecutive Officer, Director, Promoter
- David McElligottExecutive Officer, Promoter
- Asish XavierDirector
- James SullivanDirector
- Offering amount
- $19.9M
- Amount sold
- $19.9M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Lodo Therapeutics's investors?
- Lodo Therapeutics's investors include Pfizer Venture Investments, AbbVie, Alexandria, ARCH Venture Partners, Digitalis Ventures.
- How much funding has Lodo Therapeutics raised?
- Lodo Therapeutics has disclosed $19.9M raised across 1 round.
- Where is Lodo Therapeutics headquartered?
- Lodo Therapeutics is headquartered in New York, US.